Delivery Order SPE2DB22D2211-SPE2DB25FRNUT

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,899.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,543.96, is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award, valued at $8,979.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with a ceiling value of $1,651.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $7,481.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. This contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $11,809.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 25, 2024. It is not designated as a set-aside contract,...
This federal contract award, valued at $3,245.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Trulicity 1.5 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of January 24, 2022 and utilizes a firm fixed price pricing type. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,942.92, is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for diabetes management. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $5,072.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has a completion date of June 3, 2024 and is structured as a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $18,037.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat diabetes. The IDC with the DLA Troop Support Medical, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRNUT
    Delivery Order

This federal contract award, valued at $10,810.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for diabetes management. The contract has an ultimate completion date of January 14, 2025.

This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with a set-aside requirement, indicating open competition.

Generated 4/14/25, 10:44 AM